Literature DB >> 3908685

Cytokine production in inflammatory bowel disease.

M Miura, N Hiwatashi.   

Abstract

Cytokine production from peripheral blood mononuclear cells, T-cell subsets and Ia positive monocytes in patients with inflammatory bowel disease were investigated. 26 patients with Crohn's disease (CD), 7 patients with ulcerative colitis (UC) and age and sex matched healthy donors (HD) as controls were studied. No differences were seen between UC and HD in any of the parameters examined. However, impairment of interleukin 2 and interferon production was noted in CD. They cannot be attributable to decreased number of T cells, because no significant differences were seen in the number of T cells including subsets. On the other hand, regarding interleukin 1 production, no differences were seen between HD and CD. These results suggest that some form of dysfunction exists at the T-cell level in the peripheral blood in CD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908685

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  10 in total

1.  Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease.

Authors:  J Brynskov; M B Hansen; C Reimert; K Bendtzen
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

2.  The role of interferon gamma in the pathogenesis of Crohn's disease.

Authors:  T Sasaki; N Hiwatashi; H Yamazaki; M Noguchi; T Toyota
Journal:  Gastroenterol Jpn       Date:  1992-02

Review 3.  Production of inflammatory cytokines in the intestinal lamina propria.

Authors:  C Fiocchi
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Cytokine production in patients with inflammatory bowel disease.

Authors:  M Nakamura; H Saito; J Kasanuki; Y Tamura; S Yoshida
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

Review 5.  Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy.

Authors:  A B Hawthorne; C J Hawkey
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

6.  Molecular mechanism of interleukin-2-induced mucosal homeostasis.

Authors:  Jayshree Mishra; Christopher M Waters; Narendra Kumar
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-23       Impact factor: 4.249

7.  Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients.

Authors:  L Manzano; M Alvarez-Mon; J A Vargas; J A Girón; L Abreu; A Fernández-Corugedo; L I Román; F Albarran; A Durántez
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

8.  Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

Review 9.  Inflammatory mediators in chronic inflammatory bowel diseases.

Authors:  V Gross; T Andus; H G Leser; M Roth; J Schölmerich
Journal:  Klin Wochenschr       Date:  1991-12-15

10.  Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

Authors:  J Brynskov; N Tvede
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.